Hydroxyurea and splenic irradiation-induced tumour lysis syndrome: A case report and review of the literature

Journal of Clinical Pharmacy and Therapeutics

Volumn 30, Issue 6, 2005, Pages 623-625

  Chen, S W ^a   Hwang, W S ^a   Tsao, C J ^a   Liu, H S ^b   Huang, G C ^a,b  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Checkpoint; Chronic myeloid leukaemia; Hydroxyurea; Splenic irradiation; Tumour lysis syndrome

Indexed keywords

ALLOPURINOL; HYDROXYUREA; ANTINEOPLASTIC AGENT;

AGED; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CHRONIC KIDNEY FAILURE; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; DRUG EFFECT; HEMODIALYSIS; HUMAN; HUMAN TISSUE; HYDRATION; IRRADIATION; MALE; METABOLIC ACIDOSIS; SPLEEN; SYMPTOM; TUMOR LYSIS SYNDROME; MYELOID LEUKEMIA; RADIATION EXPOSURE; RENAL REPLACEMENT THERAPY; SPLENOMEGALY;

AGED; ALLOPURINOL; ANTINEOPLASTIC AGENTS; HUMANS; HYDROXYUREA; LEUKEMIA, MYELOID, CHRONIC-PHASE; MALE; RENAL DIALYSIS; SPLEEN; SPLENOMEGALY; TUMOR LYSIS SYNDROME;

EID: 33644985831     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2005.00684.x     Document Type: Article

References (18)

1. Ellis AK, Lee DH (2002) Tumor lysis syndrome induced by hydroxyurea therapy for leukemic transformation of polycythemia vera. American Journal of Hematology, 71, 237 238.
2. Seki JT, Al-Omar HM, Amato D, Sutton DM (2003) Acute tumor lysis syndrome secondary to hydroxyurea in acute myeloid leukemia. The Annals of Pharmacotherapy, 37, 675 678.
3. Bedrna J, Polcak J (1929) Akuter Harnleiterverschluss nach Bestralung chronischer Leukamien mit Roentgenstralen. Medizinische Klinik, 25, 1700 1701.
4. Merrill D (1940) Uremia following X-ray therapy in leukemia. The New England Journal of Medicine, 222, 94 97.
5. Seftel MD, Bruyere H, Copland M et al. (2002) Fulminant tumour lysis syndrome in acute myelogenous leukaemia with inv(16)(p13;q22). European Journal of Haematology, 69, 193 199.
6. Nakhoul F, Green J, Abassi ZA, Carter A (1996) Tumor lysis syndrome induced by fludarabine monophosphate: a case report. European Journal of Haematology, 56, 254 255.
7. Theodor S, Amos C, Uri H (1999) Lewinski: severe tumor lysis syndrome following splenic irradiation. American Journal of Hematology, 60, 75 76.
8. Fleming DR, Henslee-Downey PJ, Coffey CW (1991) Radiation-induced acute tumor lysis syndrome in the bone marrow transplant setting. Bone Marrow Transplantation, 8, 235 236.
9. Nishii K, Katayama N, Maeda H et al. (2001) Successful treatment with low-dose splenic irradiation for massive splenomegaly in an elderly patient with hairy-cell leukemia. European Journal of Haematology, 67, 255 257.
10. Sinclair WK (1968) The combined effect of hydroxyurea and X-rays on Chinese hamster cells in vitro. Cancer Research, 28, 198 206.
11. Levin VA (1992) The place of hydroxyurea in the treatment of primary brain tumors. Seminars in Oncology, 19 (3 Suppl. 9 34 39.
12. Richard GJ, Chambers RG (1973) Hydroxyurea in the treatment of neoplasms of the head and neck. American Journal of Surgery, 126, 513 518.
13. Vokes EE, Vijayakumar S, Hoffman PC et al. (1990) 5-Fluorouracil with oral leukovorin and hydroxyurea and concomitant radiotherapy for stage III non-small cell lung cancer. Cancer, 66, 437 442.
14. Leyden D, Ahmed N, Hassan HT (2000) Hydroxyurea and trimidox enhance the radiation effect in human pancreatic adenocarcinoma cells. Anticancer Research, 20, 133 138.
15. Ross C (1992) Donehower: an overview of the clinical experience with hydroxyurea. Seminars in Oncology, 19 (3 Suppl. 9 11 19.
16. Kuo ML, Kinsella TJ (1998) Expression of ribonucleotide reductase after ionizing radiation in human cervical carcinoma cells. Cancer Research, 58, 2245 2252.
17. Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell JE (2000) Molecular Cell Biology, 4th edn. New York : W. H. Freeman & Co., 495 536.
18. Cooper GM (2000) The Cell - A Molecular Approach, 2nd edn. Sunderland, MA, USA : Sinauer Associates, Inc 983 1026.